Table 2.
Detailed information on all cases, including tumour type and associated genes with allelic loss for various tissue
| Case No | Pathology | Cytology | Path-LOH* | Cyto-LOH† | Normal-LOH‡ |
| 1 | Pancreatic cancer | Positive | k-ras,RIZ,VHL,PTEN,P53 | k-ras,RIZ,VHL,PTEN,P53 | No LOH |
| 2 | Pancreatic cancer | Positive | k-ras,RIZ,VHL,P16,P53 | k-ras,RIZ,P16,P53 | No LOH |
| 3 | Pancreatic cancer | Positive | RIZ,P16 | RIZ,P16 | No LOH |
| 4 | Pancreatic cancer | Positive | k-ras,VHL,APC,P16,PTEN | k-ras,VHL,APC,P16,PTEN | No LOH |
| 5 | Cholangiocarcinoma | Positive | VHL,APC,P16,P53 | VHL,APC,P16,P53 | No LOH |
| 6 | Cholangiocarcinoma | Positive | APC,PTEN | APC,PTEN | No LOH |
| 7 | Cholangiocarcinoma | Positive | VHL,PTEN,P53 | VHL,PTEN,P53 | No LOH |
| 8 | Cholangiocarcinoma | Positive | RIZ,APC,PTEN | RIZ,VHL,APC,PTEN | No LOH |
| 9 | Pancreatic cancer | Inconclusive | k-ras, VHL,APC,P16,P53 | k-ras, VHL,APC,P16,P53 | No LOH |
| 10 | Pancreatic cancer | Inconclusive | k-ras, VHL,APC | k-ras, VHL,APC | No LOH |
| 11 | Cholangiocarcinoma | Inconclusive | RIZ,APC | RIZ,APC | No LOH |
| 12 | Cholangiocarcinoma | Inconclusive | APC,P16,PTEN | VHL,APC,P16,PTEN | No LOH |
| 13 | Cholangiocarcinoma | Inconclusive | RIZ,VHL,P16,P53 | VHL,P53 | No LOH |
| 14 | Cholangiocarcinoma | Inconclusive | RIZ,APC,P16,PTEN | RIZ,APC,P16,PTEN | No LOH |
| 15 | Cholangiocarcinoma | Inconclusive | VHL,P16,P53 | P16,P53 | No LOH |
| 16 | Cholangiocarcinoma | Inconclusive | RIZ,APC,P16,PTEN | APC,P16,PTEN | No LOH |
| 17 | Cholangiocarcinoma | Inconclusive | RIZ,PTEN,P53 | RIZ,PTEN | No LOH |
| 18 | Inflammatory | Inconclusive | No PATH | No LOH | No LOH |
| 19 | Inflammatory | Benign | No LOH | No LOH | No LOH |
| 20 | Inflammatory | Benign | No LOH | No LOH | |
| 21 | Inflammatory | Benign | No LOH | ||
| 22 | Inflammatory | Benign | No LOH | ||
| 23 | Inflammatory | Benign | No LOH | ||
| 24 | Inflammatory | Benign | No LOH | ||
| 25 | Inflammatory | Benign | No LOH | ||
| 26 | Inflammatory | Benign | No LOH |
*Path-LOH, loss of heterozygosity (LOH) in the surgically resected tumour, following microdissection.
†Cyto-LOH, LOH in cells from the cytology specimen.
‡Normal-LOH, LOH in normal tissue adjacent to the tumour.